| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.29 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |